ClinicalTrials.Veeva

Menu

Genetic Polymorphisms Associated With Vertebral Osteochondrosis (OSTEOGEN)

I

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Status

Unknown

Conditions

Spinal Osteochondrosis

Treatments

Genetic: presence of genetic variants

Study type

Observational

Funder types

Other

Identifiers

NCT04195529
OSTEOGEN

Details and patient eligibility

About

The present study is proposed for the identification of phenotype, biochemical and genetic markers in adult symptomatic spinal osteochondrosis to promote the early diagnosis of this pathological condition and to establish possible therapeutic targets that favor a conservative approach aimed at treating patients.

Full description

The primary outcome is to determine the association between specific phenotypic characteristics of osteochondrosis, in particular linked to osteo-cartilaginous degeneration, with the identified vitamin D receptor genotypes.

The secondary outcomes are to evaluate the circulating levels of the osteo-cartilage degradation markers, of the vitamin D and to evaluate the association of the osteochondrosis phenotype with variants in genes involved in inflammatory processes.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • males and females
  • 18≤age ≤ 65 years old
  • patients with adult spinal osteochondrosis Exclusion criteria
  • age < 18 or > 65 years old
  • chronic major diseases such as diabetes, autoimmune diseases, cardiovascular diseases, malignancies

Trial contacts and locations

1

Loading...

Central trial contact

Elena Cittera; Alessandra Colombini

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems